Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community.

Jeon, C Y; Calver, A D; Victor, T C; Warren, R M; Shin, S S; Murray, M B

Jeon, C Y; Calver, A D; Victor, T C; Warren, R M; Shin, S S; Murray, M B.

Affiliation

Jeon CY; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA. christie.jeon@gmail.com

Int J Tuberc Lung Dis ; 15(1): 77-83, 2011 Jan.

Article in En | MEDLINE | ID: mdl-21276301

Subject(s)

Anti-Bacterial Agents/adverse effects; Antitubercular Agents/administration & dosage; Fluoroquinolones/adverse effects; Gold; Mining; Mycobacterium tuberculosis/isolation & purification; Sputum/microbiology; Tuberculosis/drug therapy; Adult; Chi-Square Distribution; DNA Gyrase/genetics; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Female; Humans; Logistic Models; Male; Middle Aged; Mutation; Mycobacterium tuberculosis/genetics; Odds Ratio; Risk Assessment; Risk Factors; South Africa; Time Factors; Treatment Outcome; Tuberculosis/diagnosis; Tuberculosis/microbiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sputum / Tuberculosis / Fluoroquinolones / Gold / Mining / Anti-Bacterial Agents / Mycobacterium tuberculosis / Antitubercular Agents Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Int J Tuberc Lung Dis Year: 2011 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links